How to Track Ovulation and Find Your Fertile Window

Timing intercourse to the fertile window is one of the most practical things you can do when you're trying to conceive. The biology is straightforward: an egg is viable for only 12–24 hours after ovulation, but sperm can survive in the reproductive tract for up to five days. That creates a window of roughly five to six days per cycle — and if you're not tracking, you may not know when that window opens.

The good news is that several well-validated methods exist for identifying and confirming ovulation, each with its own trade-offs. This guide walks through each one clearly, so you can choose the approach that fits your situation.

How do ovulation predictor kits (OPKs) work — and what can't they tell you?

Ovulation predictor kits measure the LH surge — the sharp rise in luteinizing hormone that the pituitary gland releases roughly 24–36 hours before an egg is released. A positive OPK means your surge has been detected; ovulation is expected soon. It does not confirm that ovulation actually occurred.

The two dominant OPK formats are line-based strips and digital monitors:

• Line-based strips (e.g., Easy@Home, paired with the Premom app) are read by comparing the test line to a reference line. The Premom app photographs the strip and tracks LH trends algorithmically. They're the lowest-cost option — roughly $0.30–$0.40 per strip. A peer-reviewed pilot study published in PubMed Central found Premom detected the LH surge in 82% of cycles, with peak-day correlation to Clearblue of r = 0.99 when the surge was detected. However, Premom reached a $200,000 FTC settlement in May 2023 after the agency found it had shared sensitive reproductive health data with third-party analytics firms without user consent — a data-privacy consideration worth knowing before you use the app.
• The Clearblue Advanced Fertility Monitor, made by Swiss Precision Diagnostics, tracks both LH and the estrogen metabolite estrone-3-glucuronide (E3G), displaying results as Low, High, or Peak. Tracking E3G identifies the two to three fertile days before the LH surge — important because your most fertile days begin before the peak. Clearblue reports 99% accuracy for hormone detection, and the same pilot study found the monitor detected the LH surge in 94% of cycles, with significantly higher user satisfaction than line strips. The device requires proprietary refill test sticks (~$49–$59 per 30-count box).

Both Clearblue and standard OPKs share a fundamental limitation: they predict ovulation, they do not confirm it. Some women — particularly those with PCOS — experience LH surges without releasing an egg (called a luteinized unruptured follicle, or LUF). If you've been getting positive OPKs but haven't conceived after several cycles, progesterone confirmation testing is the next step.

What does BBT charting show — and when is it most useful?

Basal body temperature (BBT) charting means measuring your resting temperature every morning before getting out of bed, using a thermometer that resolves to at least two decimal places. After ovulation, progesterone secreted by the corpus luteum causes a sustained temperature rise of approximately 0.2–0.5°C (0.4–1.0°F) that persists through the luteal phase.

This thermal shift confirms ovulation happened — but only retrospectively. By the time you see the rise, the egg has already been released. That makes BBT charting most useful for:

• Identifying ovulation patterns over multiple cycles so you can better anticipate your fertile window in future cycles
• Detecting a consistently short luteal phase (fewer than 10 days from ovulation to the next period), which can be a sign of luteal phase insufficiency
• Confirming that an OPK surge led to actual ovulation

Natural Cycles — the only app in the United States with FDA De Novo classification as a contraceptive method — is built on a BBT algorithm. In March 2026, Garmin announced a product integration extending wrist-temperature syncing to compatible Garmin smartwatches (Forerunner 970, Venu X1), joining existing integrations with Oura Ring and Apple Watch. KFF data from 2024 show that 13% of women ages 18–49 use fertility-awareness-based methods — a number that has grown alongside mainstream interest in cycle literacy.

BBT accuracy is undermined by poor sleep (under six hours), illness, alcohol consumed the night before, or travel across time zones. Consistency — measuring at the same time each morning under the same conditions — is what makes the chart interpretable.

How does cervical mucus fit into ovulation tracking?

Cervical mucus is produced by glands in the cervix and changes predictably in response to estrogen and progesterone across the cycle. Learning to observe it adds a real-time, cost-free layer of information that complements both OPKs and BBT.

Here is how mucus typically changes across a cycle:

• Immediately after menstruation: Little to no mucus; a dry or absent sensation at the vaginal opening.
• Pre-ovulatory phase: Mucus appears, initially sticky or thick and white or yellow — not favorable to sperm.
• Approaching ovulation: Rising estrogen transforms mucus into the fertile type: clear, slippery, stretchy — resembling raw egg white (EWCM). This "egg-white" mucus actively supports sperm survival and motility, helping sperm survive long enough to meet the egg.
• After ovulation: Rising progesterone thickens mucus back to a sticky, creamy, or absent state that blocks sperm.

The peak mucus day — the last day of egg-white mucus before it thickens — is closely correlated with ovulation and is one of the most reliable real-time fertility signals you can observe without any device.

A note from a functional-medicine perspective: hydration, arousal, vaginal infections, and some antihistamines can affect mucus appearance. If you frequently observe no clear mucus at all before your expected ovulation, it's worth mentioning to your provider, as consistently scant cervical mucus can be associated with estrogen insufficiency or prior cervical procedures.

What does progesterone (PdG) testing add — and who needs it most?

Standard OPKs can tell you that an LH surge occurred. BBT can tell you that a temperature shift followed. But neither tells you how much progesterone your corpus luteum is producing — a question that matters for implantation and early pregnancy maintenance.

Two devices now measure urinary pregnanediol-3-glucuronide (PdG), the main urinary metabolite of progesterone, alongside LH and estrogen:

• Inito Fertility Monitor: Tracks LH, E3G, PdG, and FSH on a single strip. Published research in Nature's Scientific Reports reports ovulation confirmation specificity above 99% and 92.2% precision; a study in Human Reproduction Open found 95% accuracy versus blood hormone trends. The starter kit (InSight Wireless Reader + 15 strips) retails at $119, with refill packs at $49 for 15 strips. The standard device requires iPhone 7 or newer; Android is supported via the InSight Wireless Reader peripheral.
• Mira Hormone Monitor: Quantifies hormone concentrations numerically (LH, FSH, E3G, PdG) using fluorescent detection technology. Mira's Confirm (PdG) wand holds FDA clearance for the U.S. market. The Mira Ultra4 Kit retails at approximately $249 for 20 wands; replacement wands run $2–$4.50 each. The companion app is trained on 30 million hormone data points.

From a functional standpoint, PdG confirmation is most valuable for women with suspected luteal phase insufficiency — a root cause of implantation failure and early pregnancy loss that conventional workups sometimes miss. The PiNC Trial, a 2025 randomized controlled trial published in BJOG, found that vaginal micronized progesterone (400 mg twice daily) during the luteal phase more than doubled live birth rates in women with unexplained infertility (15.3% vs 7.0%) — though the trial was underpowered and results did not reach conventional statistical significance, warranting a larger confirmatory study. If your at-home PdG results are consistently low after an LH surge, bring that data to your provider rather than self-treating.

How do you put these methods together, and when should you seek clinical evaluation?

For most women with regular cycles and no known fertility concerns, a two-method approach works well in practice: OPKs beginning a few days before your expected fertile window (to catch the LH surge in real time) plus cervical mucus observation (to identify the fertile window's opening). BBT can be added to confirm ovulation occurred, and PdG testing is a logical third layer if you want quantitative progesterone data or have reason to suspect ovulatory dysfunction.

Women with irregular cycles, known PCOS, a history of anovulation, or prior early pregnancy losses will get more from the full four-method picture — or from one of the multi-hormone monitors (Inito or Mira) that provide quantitative data your provider can act on.

Tracking is a tool, not a treatment. ASRM's evaluation thresholds are clear: seek evaluation after 12 months of regular, unprotected intercourse if you're under 35; after 6 months if you're 35–39; and immediately at age 40 or older. Do not wait for these timelines if you have irregular periods, known PCOS, a history of ectopic pregnancy or pelvic inflammatory disease, or endometriosis. RESOLVE: The National Infertility Association estimates 1 in 8 couples in the U.S. experiences difficulty conceiving — early evaluation provides information, not a commitment to treatment.

This article is general health information, not medical advice. Please speak with your OB-GYN, midwife, or reproductive specialist about your personal cycle, any symptoms you're experiencing, and what tracking approach makes the most sense for your situation.